Peter van Sluis

17.5k citations

35 papers · 3.5k indexed · 1 hit paper · h-index 25

Impact in

Neurology top 0.5%
- Neuroblastoma Research and Treatments
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism

Papers in

Neurology 30
- Neuroblastoma Research and Treatments 30
Cancer Research 13
- Cancer, Hypoxia, and Metabolism 13

Co-authors: Rogier Versteeg Huib N. Caron Jan Köster Kathy Boon Jan J. Molenaar P.A. Voûte Linda J. Valentijn Jan de Kraker
Journals: Genes Chromosomes and Cancer (7 papers)Cancer Research (3 papers)Oncogene (3 papers)European Journal of Cancer (2 papers)Human Genetics (2 papers)
Partner nations: Netherlands Germany Belgium

In The Last Decade

Peter van Sluis

35 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

The Human Transcriptome Map: Clustering of Highly Expressed Genes in Chromosomal Domains 2001 · 571 citations

Peers

Countries citing papers authored by Peter van Sluis

Since Specialization

Citations

This map shows the geographic impact of Peter van Sluis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter van Sluis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter van Sluis more than expected).

Fields of papers citing papers by Peter van Sluis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter van Sluis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter van Sluis. The network helps show where Peter van Sluis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter van Sluis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter van Sluis Line = papers co-authored together Peter van Sluis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma Nature Communications ·Tim van Groningen, Nurdan Akogul, Ellen M. Westerhout, Alvin Chan, Nancy E. Hasselt, Danny A. Zwijnenburg, Marloes E.C. Broekmans, Peter Stroeken, Franciska Haneveld, Gerrit K. Hooijer, C. Dilara Savci‐Heijink, Arjan Lakeman, Richard Volckmann, Peter van Sluis, Linda J. Valentijn, Jan Köster, Rogier Versteeg, Johan van Nes	2019	95
2	RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma Cancer Research ·Thomas F. Eleveld, Linda Schild, Jan Köster, Danny A. Zwijnenburg, Lindy K. Alles, Marli E. Ebus, Richard Volckmann, 學嗣郎河本, Peter van Sluis, Rogier Versteeg, Jan J. Molenaar	2018	40
3	FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma Cancer Research ·Evan E. Santo, Peter Stroeken, Peter van Sluis, Jan Köster, Rogier Versteeg, Ellen M. Westerhout	2013	117
4	A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma Clinical Cancer Research ·Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg	2013	33
5	Identification of BIRC6 as a novel intervention target for neuroblastoma therapy BMC Cancer ·Fieke Lamers, Linda Schild, Jan Köster, Frank Speleman, Ingrid Øra, Ellen M. Westerhout, Peter van Sluis, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar	2012	22
6	Copy number defects of G1‐Cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis Genes Chromosomes and Cancer ·Jan J. Molenaar, Jan Köster, Marli E. Ebus, Peter van Sluis, Ellen M. Westerhout, Katleen De Preter, David Gisselsson, Ingrid Øra, Frank Speleman, Huib N. Caron, Rogier Versteeg	2011	54
7	MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3 Cancer Letters ·Ingrid Revet, M Zanteva-Naumovska, Jan Köster, Richard Volckmann, Peter van Sluis, Rogier Versteeg, Dirk Geerts	2009	40
8	Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features PLoS ONE ·Marcel Kool, Jan Köster, Jens Bunt, Nancy E. Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N. Caron, Jacqueline Cloos, Subodh Kumar Kundu, Bauke Ylstra, Wiesława Grajkowska, Wolfgang Hartmann, Torsten Pietsch, David W. Ellison, Steven C. Clifford, Rogier Versteeg	2008	491
9	The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta–Notch pathway in neuroblastoma Experimental Cell Research ·Ingrid Revet, M Zanteva-Naumovska, Alvin Chan, Jan Köster, Richard Volckmann, Peter van Sluis, Ingrid Øra, Rogier Versteeg, Dirk Geerts	2007	65
10	Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma Genes Chromosomes and Cancer ·Jan J. Molenaar, Peter van Sluis, Kathy Boon, Rogier Versteeg, Huib N. Caron	2003	58
11	The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2 Oncogene ·Marc B. Godfried, 河合雄, Peter van Sluis, Kathy Boon, Hanaa K. Egzar, Martin Sopúch, Zhixuan Duan, Tom Voûte, Manfred Schwab, Rogier Versteeg, Huib N. Caron	2002	60
12	The MEIS1 Oncogene Is Highly Expressed in Neuroblastoma and Amplified in Cell Line IMR32 Genomics ·Nicole Spieker, Peter van Sluis, M. Beitsma, Kathy Boon, Barbera D. C. van Schaik, Antoine H. C. van Kampen, S. Dufour, Rogier Versteeg	2001	59
13	N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis The EMBO Journal ·Kathy Boon, Huib N. Caron, Hanaa K. Egzar, Linda J. Valentijn, FangXu Jiang Jing Sui Munish Mehta, Peter van Sluis, Ilja Roobeek, А. А. Никитина, P.A. Voûte, Manfred Schwab, Rogier Versteeg	2001	355
14	Three chromosomal rearrangements in neuroblastoma cluster within a 300‐kb region on 1p36.1 Genes Chromosomes and Cancer ·Weissmann Nm, M. Beitsma, Peter van Sluis, Alvin Chan, Huib N. Caron, Rogier Versteeg	2001	20
15	SAGE analysis of neuroblastoma reveals a high expression of the human homologue of theDrosophila Delta gene Medical and Pediatric Oncology ·Bülent Batmaz, Alvin Chan, Huib N. Caron, Peter van Sluis, Kathy Boon, Hyunsuk Yun, Rogier Versteeg	2000	36
16	An integrated 5‐Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis Genes Chromosomes and Cancer ·Nicole Spieker, M. Beitsma, Peter van Sluis, Ilja Roobeek, Johan T. den Dunnen, Frank Speleman, Huib N. Caron, Rogier Versteeg	2000	2
17	A constitutional balanced 1;17 neuroblastoma translocation European Journal of Cancer ·Terezinha Fatima de Souza, Peter van Sluis, Jan de Kraker, J.P.M. Bökkerink, Maarten Egeler, Geneviève Laureys, Voûte Pa, R Släter, A. Westerveld, Rogier Versteeg	1997	1
18	Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus Human Genetics ·Huib N. Caron, Peter van Sluis, Rodney M. Zerbe, Gabrielle Murnan, 啓治副島, Shangguan Da-fu, Jan de Kraker, P.A. Voûte, Gilles Vergnaud, A. Westerveld, Rosalyn Slater, Rogier Versteeg	1996	47
19	Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification Human Molecular Genetics ·Huib N. Caron, Martine Peter, Peter van Sluis, Frank Speleman, Jan de Kraker, Geneviève Laureys, Jean Michon, Laurence Brugières, P.A. Voûte, A. Westerveld, Rosalyn Slater, Olivier Delattre, Rogier Versteeg	1995	126
20	Inactivation of transforming Bacillus subtilis deoxyribonucleic acid by monoadducts of 4,5',8-trimethylpsoralen Journal of Bacteriology ·Sam Stobart, Peter van Sluis, G Venema	1981	4

About Peter van Sluis

Peter van Sluis is a scholar working on Neurology, Cancer Research, Cell Biology, Molecular Biology and Genetics, having authored 35 papers that have together received 3.5k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (30 papers), Cancer, Hypoxia, and Metabolism (13 papers), Microtubule and mitosis dynamics (4 papers), Cell death mechanisms and regulation (4 papers), Ubiquitin and proteasome pathways (4 papers), Virus-based gene therapy research (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Chromatin Remodeling and Cancer (3 papers). The work is most often cited by research in Neurology (1.5k citations), Cancer Research (919 citations), Genetics (408 citations), Molecular Biology (2.6k citations) and Oncology (573 citations). Peter van Sluis has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include Rogier Versteeg, Huib N. Caron, Jan Köster, Kathy Boon, Jan J. Molenaar, P.A. Voûte, Linda J. Valentijn, Jan de Kraker, Frank Baas and Nancy E. Hasselt. Their work appears in journals such as Genes Chromosomes and Cancer, Cancer Research, Oncogene, European Journal of Cancer and Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact